Sanofi Consumer Healthcare India balance sheet

As of Dec 2025

Total assets: ₹547cr+26.8% on Dec 2024
Shareholders' equity: ₹384cr+40.7% on Dec 2024
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹375cr+14.7% on Dec 2024

₹ crore except per share

Tap a line for its trend	FY26Dec 2025	FY25Dec 2024

Non-current assets
	35.1	27.2
	0.0	0.7
	0.8	1.9
	3.2	3.6
	3.2	3.6
	8.5	6.2
	5.1	0.0
	52.7	39.6
Current assets
	61.9	40.9
	29.6	13.7
	375	327
	0.4	0.0
	0.1	0.6
	0.0	3.8
	405	345
	27.5	5.8
	494	392
	547	431
Equity
	23.0	23.0
	361	250
	384	273
	384	273
Liabilities
	34.6	16.6
	34.6	16.6
	0.0	11.1
	34.6	27.7
	79.6	70.3
	10.0	3.7
	89.6	74.0
	35.8	42.2
	0.0	0.3
	3.0	14.1
	128	131
	163	158
	547	431
Trade payables — MSME split
	5.2	—
	74.4	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SANOFICONR₹3,322.80

Sanofi Consumer Healthcare India Limited

· Pharma & Health

₹ CrorePeersPGHL SANOFI SENORES INNOVACAP MOREPENLAB IOLCP FDC ASTRAZENMcap ₹7,642 Cr

View

In ₹ Crore except Per Share As of	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	27.2	35.1	35.1
+ Capital Work-in-Progress	0.7	0.0	0.0
+ Other Intangibles	1.9	0.8	0.8
+ Other Non-current Financial Assets	3.6	3.2	3.2
Non-current Financial Assets	3.6	3.2	3.2
+ Deferred Tax Assets	6.2	8.5	8.5
+ Other Non-current Assets	0.0	5.1	5.1
Total Non-current Assets	39.6	52.7	52.7
Current Assets
+ Inventories	40.9	61.9	61.9
+ Trade Receivables	13.7	29.6	29.6
+ Cash & Cash Equivalents	326.9	374.8	374.8
+ Other Bank Balances	0.0	0.4	0.4
+ Short-term Loans	0.6	0.1	0.1
+ Other Current Financial Assets	3.8	0.0	0.0
Current Financial Assets	345.0	404.9	404.9
+ Other Current Assets	5.8	27.5	27.5
Total Current Assets	391.7	494.3	494.3
Total Assets	431.3	547.0	547.0
Equity
+ Equity Share Capital	23.0	23.0	23.0
+ Other Equity / Reserves	250.0	361.0	361.0
Equity — Owners of Parent	273.0	384.0	384.0
Total Equity	273.0	384.0	384.0
Liabilities
+ Other Non-current Financial Liab	16.6	34.6	34.6
Non-current Financial Liabilities	16.6	34.6	34.6
+ Provisions — Non-current	11.1	0.0	0.0
Non-current Liabilities	27.7	34.6	34.6
+ Trade Payables	70.3	79.6	79.6
+ Other Current Financial Liab	3.7	10.0	10.0
Current Financial Liabilities	74.0	89.6	89.6
+ Provisions — Current	42.2	35.8	35.8
+ Current Tax Liabilities	0.3	0.0	0.0
+ Other Current Liabilities	14.1	3.0	3.0
Current Liabilities	130.6	128.4	128.4
Total Liabilities	158.3	163.0	163.0
Total Equity & Liabilities	431.3	547.0	547.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	5.2	5.2
+ Dues to Other Creditors — Current	—	74.4	74.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.